Deploying blood-based cancer screening

Science. 2024 Jan 26;383(6681):368-370. doi: 10.1126/science.adk1213. Epub 2024 Jan 25.

Authors

Douglas S Micalizzi^{1

2}, Lecia V Sequist², Daniel A Haber^{1

2

3}

Affiliations

¹ Krantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA, USA.
² Department of Medicine and Massachusetts General Hospital Cancer Center, Harvard Medical, School, Boston, MA, USA.
³ Howard Hughes Medical Institute, Chevy Chase, MD, USA.

PMID: 38271495
DOI: 10.1126/science.adk1213

Abstract

AI-based risk assessment may enable personalized blood-based multicancer screening.

MeSH terms

Artificial Intelligence
Blood Chemical Analysis* / methods
Early Detection of Cancer* / methods
Humans
Mass Screening* / methods
Neoplasms* / blood
Neoplasms* / diagnosis